Fibrinogen gene variation and ischemic stroke

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 6, 2008, Pages 897-904

  Jood, K ^a   Danielson, J ^a   Ladenvall, C ^a,b   Blomstrand, C ^a   Jern, Cristina ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Fibrinogen; Haplotypes; Ischemic stroke

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRINOGEN; FIBRINOGEN ALPHA; FIBRINOGEN BETA; FIBRINOGEN GAMMA;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TEST; BRAIN INFARCTION; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE CLASSIFICATION; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NEUROIMAGING; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; FEMALE; FIBRINOGEN; GENOTYPE; HAPLOTYPES; HUMANS; ISCHEMIA; LINKAGE DISEQUILIBRIUM; MALE; MODELS, GENETIC; MULTIGENE FAMILY; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; STROKE; VARIATION (GENETICS);

EID: 43749099626     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.02950.x     Document Type: Article

References (35)

1. Koenig W. Fibrin(ogen) in cardiovascular disease: An update. Thromb Haemost 2003; 89: 601-9.
2. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3: 1894-904.
3. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and non-vascular mortality: An individual participant meta-analysis. JAMA 2005; 294: 1799-809.
4. Fatah K, Hamsten A, Blombäck B, Blombäck M. Fibrin gel network characteristics and coronary heart disease: Relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis. Thromb Haemost 1992; 6: 130-5.
5. Beamer NB, Coull BM, Clark WM, Briley DP, Wynn M, Sexton G. Persistent inflammatory response in stroke survivors. Neurology 1998; 50: 1722-8.
6. Tanne D, Benderly M, Goldbourt U, Boyko V, Brunner D, Graff E, Reicher-Reiss H, Shotan A, Mandelzweig L, Behar S, Bezafibrate Infarction Prevention Study Group. A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study. Am J Med 2001; 111: 457-63.
7. Di Napoli M, Papa F, Villa Pini Stroke Data Bank Investigators. Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients. Stroke 2002; 33: 1763-71.
8. Rothwell PM, Howard SC, Power DA, Gutnikov SA, Algra A, van Gijn J, Clark TG, Murphy MF, Warlow CP. Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke. Stroke 2004; 35: 2300-5.
9. Woodward M, Lowe GD, Campbell DJ, Colman S, Rumley A, Chalmers J, Neal BC, Patel A, Jenkins AJ, Kemp BE, MacMahon SW. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke 2005; 36: 2143-7.
10. Sato S, Iso H, Noda H, Kitamura A, Imano H, Kiyama M, Ohira T, Okada T, Yao M, Tanigawa T, Yamagishi K, Nakamura M, Naito Y, Shimamoto T. Plasma fibrinogen concentrations and risk of stroke and its subtypes among Japanese men and women. Stroke 2006; 37: 2488-92.
11. Ohira T, Shahar E, Chambless LE, Rosamond WD, Mosley TH Jr, Folsom AR. Risk factors for ischemic stroke subtypes: The Atherosclerosis Risk in Communities study. Stroke 2006; 37: 2493-8.
12. Scott EM, Ariens RA, Grant PJ. Genetic and environmental determinants of fibrin structure and function: Relevance to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 1558-66.
13. Lim BC, Ariens RA, Carter AM, Weisel JW, Grant PJ. Genetic regulation of fibrin structure and function: Complex gene-environment interactions may modulate vascular risk. Lancet 2003; 361: 1424-31.
14. Cooper AV, Standeven KF, Ariëns RA. Fibrinogen gamma-chain splice variant gamma'alters fibrin formation and structure. Blood 2003; 102: 535-40.
15. Kessler C, Spitzer C, Stauske D, Mende S, Stadlmuller J, Walther R, Rettig R. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol 1997; 17: 2880-4.
16. Blake GJ, Schmitz C, Lindpaintner K, Ridker PM. Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis. Eur Heart J 2001; 22: 2262-6.
17. van Goor MP, Gomez-Garcia EB, Leebeek FW, Brouwers GJ, Koudstaal PJ, Dippel DW. The -148 C/T fibrinogen gene polymorphism and fibrinogen levels in ischaemic stroke: A case-control study. J Neurol Neurosurg Psychiatry 2005; 76: 121-3.
18. Rubattu S, Di Angelantonio E, Nitsch D, Gigante B, Zanda B, Stanzione R, Evangelista A, Pirisi A, Rosati G, Volpe M. Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population. Thromb Haemost 2005; 93: 1095-100.
19. Carter AM, Catto AJ, Grant PJ. Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation. Circulation 1999; 99: 2423-6.
20. Carter AM, Catto AJ, Bamford JM, Grant PJ. Gender-specific associations of the fibrinogen B beta 448 polymorphism, fibrinogen levels, and acute cerebrovascular disease. Arterioscler Thromb Vasc Biol 1997; 17: 589-94.
21. Kathiresan S, Yang Q, Larson MG, Camargo AL, Tofler GH, Hirschhorn JN, Gabriel SB, O'Donnell CJ. Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk. Arterioscler Thromb Vasc Biol 2006; 26: 1405-12.
22. Voetsch B, Loscalzo J. Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol 2004; 24: 216-29.
23. Jood K, Ladenvall C, Rosengren A, Blomstrand C, Jern C. Family history in ischemic stroke before 70years of age: The Sahlgrenska Academy Study on Ischemic Stroke. Stroke 2005; 36: 1383-7.
24. Ladenvall C, Jood K, Blomstrand C, Nilsson S, Jern C, Ladenvall P. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 2006; 37: 2018-23.
25. Mannila MN, Eriksson P, Lundman P, Samnegard A, Boquist S, Ericsson CG, Tornvall P, Hamsten A, Silveira A. Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction. Thromb Haemost 2005; 93: 570-7.
26. Tjarnlund A, Andersson M, Jood K, Ladenvall P, Jern C. Rapid genotyping of haemostatic gene polymorphisms using the 5′ nuclease assay. Thromb Haemost 2003; 89: 936-42.
27. Becker T, Knapp M. Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet Epidemiol 2004; 27: 21-32.
28. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5.
29. Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001; 32: 133-8.
30. Tybjaerg-Hansen A, Agerholm-Larsen B, Humphries SE, Abildgaard S, Schnohr P, Nordestgaard BG. A common mutation (G-455→A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. J Clin Invest 1997; 99: 3034-9.
31. Mannila MN, Silveira A, Hawe E, Eriksson P, Aillaud MF, Juhan-Vague I, Yudkin J, Margaglione M, di Minno G, Mussoni L, Tremoli E, Humphries S, Hamsten A, The HIFMECH Study Group. Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: Effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study. Thromb Haemost 2004; 92: 1240-9.
32. van Oijen M, Cheung EY, Geluk CE, Hofman A, Koudstaal PJ, Breteler MM, de Maat MP. Haplotypes of the fibrinogen gene and cerebral small vessel disease. The Rotterdam scan study. J Neurol Neurosurg Psychiatry 2007; doi: 10.1136/jnnp.2006.113035.
33. Uitte de Willige S, de Visser MC, Houwing-Duistermaat JJ, Rosendaal FR, Vos HL, Bertina RM. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma'levels. Blood 2005; 106: 4176-83.
34. Uitte de Willige S, Doggen CJ, de Visser MC, Bertina RM, Rosendaal FR. Haplotypes of the fibrinogen gamma gene do not affect the risk of myocardial infarction. J Thromb Haemost 2006; 4: 474-6.
35. Kardys I, Uitterlinden AG, Hofman A, Witteman JC, de Maat MP. Fibrinogen gene haplotypes in relation to risk of coronary events and coronary and extracoronary atherosclerosis: The Rotterdam Study. Thromb Haemost 2007; 97: 288-95.